05May
[Webinar] Diagnostics, Antibody Testing and Vaccines: Global Outlook on Life Sciences COVID-19 Advances and Evolving Deal Trends - May 7th, 11:00 am - 12:15 pm EDT
Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team will examine the current...
By:
McDermott Will & Emery
Related
Corporate Partner Dave Dallas provides executives with a concise and creative list of suggestions an...
Read More >
Report on Supply Chain Compliance 3, no. 1 (January 9, 2020) - A bipartisan push by the United Stat...
Read More >
On 24 March 2020, the Government of Vietnam promulgated Decree No. 35/2020/ND-CP setting forth, amon...
Read More >
On October 11, 2019, Governor Gavin Newsom signed into law Assembly Bill (AB) 25, which amends the C...
Read More >
As we shifted focus last week from a plan’s administrative claims procedures to defending against a...
Read More >
On June 26, 2019, Governor Ned Lamont signed a $43.4 billion budget for the 2020 and 2021 fiscal yea...
Read More >